Drug Approval | November 08, 2025
Alembic announces USFDA final approval for Dasatinib Tablets
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sprycel Tablets
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sprycel Tablets
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Adjusted EBITDA increased by 12.3 per cent to $531 million, up from $516 million in the same period last year
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Orphan drug designation (ODD) by the USFDA for Desidustat, provides eligibility for a potential seven-year marketing exclusivity subject to the USFDA approval
During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Teva reported third quarter revenues of $4.5 billion, an increase of 3 per cent year-over-year.
Subscribe To Our Newsletter & Stay Updated
